Tagged with access

Mexico Luisa Gutierrez, CEO at Medisi, explains the importance of helping get fast registration for high quality medtech products registrations and explains Medisi’s integral solutions for both the regulation and distribution of medical devices. Ms. Gutierrez you have quite an unusual professional profile. What triggered you to start your entrepreneurial journey…

Taiwan Mike Exton, Managing Director at Novartis Taiwan, describes the affiliate’s plans to increase collaboration with the government in order to provide Taiwanese patients with a greater access to innovative, life-changing products, while highlighting Novartis’ world-class innovation in many critical therapeutic areas, such as heart failure, as well as the skilled…

Taiwan The Chairman & CEO of TaiGen Biotechnology discusses the growth opportunities that the company holds in China, its main target market, and documents how her long-term strategic outlook made the company one of the most successful biotech companies in the region today, holding an unrivalled experience and unique positioning in…

Greece Despite the difficulties of the financial crisis and subsequent austerity legislation, pharma firms implanted in Greece have nonetheless continued to exhibit great commitment and staying power. “The big multinationals have not been panicking and resorting to large-scale layoffs or fleeing the market.” Konstantinos Kofinas, Merck “Regardless of the challenges posed…

Mexico Roberto Tapia-Conyer, General Director at the Carlos Slim Foundation, explains the unique position of the Foundation to develop and introduce innovation that could create breakthroughs in the National Healthcare System as well as enhance patients’ quality of life. Could you please give our international audience an update on the operations…

Greece Efthymios (Makis) Papataxiarchis, Managing Director of Janssen Pharmaceutical companies, Johnson & Johnson Greece, Malta & Cyprus, on spearheading a large multinational company through the largest economic crisis in Europe. He speaks about Janssen’s portfolio in Greece, how to mitigate challenges in market access, as well as igniting a solutions-driven dialogue…

Greece As the Executive Director of the American-Hellenic Chamber, Elias Spirtounias, is a believer in solutions. He speaks about ensuring the resiliency of the bi-lateral American and Greek relationship throughout transformative times, focusing on garnering investments for the sector, as well as creating spaces for collaboration amongst all relevant parties to…

Greece From Greece to the world – Rafarm is an example of a local champion in the midst of realizing its global ambitions. Blessed with the duality of a family-run business philosophy and extroverted internationalization strategies, Rafarm’s Vice President, Aris Mitsopoulos, proudly speaks about the company’s impressive growth, its diverse business…

Greece Amgen’s mission is clear cut: ‘To Serve Patients’, which is evident in the level of innovation that they bring as the world’s leading biotech company. Complementary to this message is one that GM of Amgen Greece Arvela Matti, strongly wants to reverberate across the Greek pharmaceutical landscape: innovation is an…

Greece Equipped with a strong business acumen, Italfarmaco (ITF) Hellas’ Managing Director, Polly Leontaridis-Kalogera emphasizes the critical importance of the decision to focus on women’s health in building a resilient affiliate in the midst of the economic crisis. She shares her insights on the beginnings of the company in Greece, transformative…

Mexico M.S. Nagendra, Director General at Zydus Pharmaceuticals Mexico, explains the company’s unique business model, combining both branded generics and highly innovative medicines, while showcasing the strategic relevance of the Mexican affiliate within the global strategy of the company. Could you introduce yourself to our international readers as well as the…

Greece  Astellas Greece & Cyprus MD, Harry Nardis, emphasizes the importance of integrity, compliance and innovation to the Astellas business model, key priorities, navigating the Greek pharmaceutical landscape while maintaining a high-quality reputation, and retaining the company’s vision of being at the forefront of healthcare change. Having assumed the leadership position…